SEC Form 4 · accession 0001731122-18-000142
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rene Sindlev
Director · 10% Owner
Period of report
Oct 17, 2017
Accepted (ET)
Nov 7, 2018 · 9:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common Stock | $2.00 | Oct 17, 2017 | P | 250,000 | A | Oct 17, 2017 | Dec 31, 2019 | Common Stock | 250,000 | 250,000 | I |